The innovative spirit is the cornerstone of America’s health care success.
The University of Miami welcomed Vice President Mike Pence to commemorate a truly impressive feat of medical innovation — a crucial step toward a COVID-19 vaccine.
Pence’s visit marked the beginning of Phase III trials of a 30,000-person study in which The Miller School will enroll 1,000 volunteers in South Florida — an area ripe for clinical trial diversity — to determine the effectiveness of a potential vaccine.